Pure Bioscience, Inc. Reports Earnings Results for the Second Quarter Ended January 31, 2021
March 15, 2021 at 04:05 pm EDT
Share
PURE Bioscience, Inc. announced earnings results for the second quarter ended January 31, 2021. For the second quarter, the company announced total revenue was USD 916,000. Operating loss was USD 594,000 compared to USD 663,000 a year ago. Net loss was USD 595,000 compared to USD 666,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the half year, total revenue was USD 2.507 million. Operating loss was USD 773,000 compared to USD 1.793 million a year ago. Net loss was USD 775,000 compared to USD 1.791 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago.
PURE Bioscience, Inc. is focused on developing and commercializing its proprietary antimicrobial products primarily in the food safety arena. The Company provides solutions to combat the health and environmental problems of pathogen and hygienic control. Its technology platform is based on patented, stabilized ionic silver, and its initial products contain silver dihydrogen citrate (SDC). SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The Company offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies. It also offers PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The Company sells its products directly and indirectly through third-party distributors.
PURE BIOSCIENCE, INC. 
